Agios Pharmaceuticals, Inc.
AGIO
$26.70
$1.395.49%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 19.70% | 4.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.70% | 4.05% | |||
| Cost of Revenue | 14.79% | -7.17% | |||
| Gross Profit | -14.11% | 8.55% | |||
| SG&A Expenses | 34.15% | 8.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.46% | -2.32% | |||
| Operating Income | -21.62% | 2.84% | |||
| Income Before Tax | -110.53% | 1,141.46% | |||
| Income Tax Expenses | -116.71% | -- | |||
| Earnings from Continuing Operations | -110.18% | 1,086.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -110.18% | 1,086.20% | |||
| EBIT | -21.62% | 2.84% | |||
| EBITDA | -21.88% | 2.65% | |||
| EPS Basic | -110.15% | 1,083.85% | |||
| Normalized Basic EPS | -19.30% | 8.57% | |||
| EPS Diluted | -110.42% | 1,058.57% | |||
| Normalized Diluted EPS | -22.42% | 10.90% | |||
| Average Basic Shares Outstanding | 0.29% | 0.24% | |||
| Average Diluted Shares Outstanding | -2.28% | 2.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
